Overview
- 13 inspections across 13 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2018-11-23.
At a glance
Inspections
13
Sites
13
Observations
1
Career since
Mar 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Boehringer Ingelheim RCV GmbH & CO KG | 23 Nov 2018 | Human Drugs | On file |
| Patheon Biologics B.V. | 13 Feb 2018 | Human Drugs | On file |
| Lonza AG | 15 Dec 2017 | Human Drugs | On file |
| Samsung Biologics Co., Ltd. | 25 Jul 2017 | Human Drugs | On file |
| Rentschler Biopharma SE | 23 May 2017 | Human Drugs | On file |
Sites inspected
Boehringer Ingelheim RCV GmbH & CO KGVienna, Austria1 insp.
Patheon Biologics B.V.Groningen, Netherlands1 insp.
Lonza AGVisp, Switzerland1 insp.
Samsung Biologics Co., Ltd.Yeonsu District, Korea (the Republic of)1 insp.
Rentschler Biopharma SELaupheim, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Wayne E Seifert3 shared
Diane L Raccasi3 shared
Zhong Li2 shared
Bo Chi2 shared
Reyes Candau-Chacon2 shared
Laura Fontan2 shared
Ram K Sihag1 shared
Richard Ledwidge1 shared
Kathleen R Jones1 shared
V Ashutosh Rao1 shared
Full investigator report
Get the verbatim findings behind Maria J Lopez- Barragan's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site